Literature DB >> 29550152

222nd ENMC International Workshop:: Myotonic dystrophy, developing a European consortium for care and therapy, Naarden, The Netherlands, 1-2 July 2016.

Libby Wood1, Guillaume Bassez2, Baziel van Engelen3, Hanns Lochmüller4, Benedikt Schoser5.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29550152     DOI： 10.1016/j.nmd.2018.02.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  3 in total

Review 1.  [Innovative therapeutic approaches for hereditary neuromuscular diseases].

Authors:  J Kirschner; B Schoser
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

2.  The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care.

Authors:  Marie De Antonio; Céline Dogan; Ferroudja Daidj; Bruno Eymard; Jack Puymirat; Jean Mathieu; Cynthia Gagnon; Sandrine Katsahian; Dalil Hamroun; Guillaume Bassez
Journal:  Orphanet J Rare Dis       Date:  2019-06-03       Impact factor: 4.123

3.  Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review.

Authors:  Erik Landfeldt; Josefin Edström; Cecilia Jimenez-Moreno; Baziel G M van Engelen; Janbernd Kirschner; Hanns Lochmüller
Journal:  Patient       Date:  2019-08       Impact factor: 3.883
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.